← FDA DRUG APPROVALS

FDA ANDA · ANDA076862

METOPROLOL SUCCINATE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA076862
TYPE
ANDA
ORIGINAL APPROVAL
2009-08-03
LATEST ACTION
2015-06-29
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued, Prescription

Products

METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 25MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEPrescription
METOPROLOL SUCCINATE EQ 50MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL

Approval history

2015-06-29Labeling · Supplement 17 · standardAP
2015-06-29Labeling · Supplement 6AP
2014-05-15Manufacturing (CMC) · Supplement 13 · unknownAP
2009-08-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →